Patents by Inventor Aventis Pharma Deutschland GmbH

Aventis Pharma Deutschland GmbH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130317047
    Abstract: The present invention relates to use of an inhibitor of the renin-anglotensin system (RAS) or a pharmaceutically acceptable derivative thereof, such as ramipril or ramiprilat, in the prevention of stroke, diabetes and/or congestive heart failure (CHF).
    Type: Application
    Filed: November 9, 2012
    Publication date: November 28, 2013
    Applicant: Aventis Pharma Deutschland GmbH
    Inventor: Aventis Pharma Deutschland GmbH